With indications that ‘“dialysis begets dialysis”’ and can obscure kidney function improvement, a novel trial shows notable ...

Meet three volunteers who are helping to provide therapeutic hand care in the community while also discovering the ‘stories behind the hand’ ...

Obesity is one of the biggest barriers preventing patients with end-stage kidney disease from receiving a life-saving kidney ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

Rilparencel, a percutaneous minimally invasive injectable product prepared from patients’ own kidney cells, is being developed to treat those with stage 3b or 4 CKD and either type 1 or type 2 ...

Donation after circulatory death (DCD) procurements provide an opportunity to alleviate the limited organ supply for solid ...

Acute kidney injury (AKI) is among the most common organ failures observed in the hospital and can irrevocably alter the trajectory of a patient's short-term and long-term health.1–4 The lack of ...